Zaurategrast is primarily investigated for its potential therapeutic applications in the field of immunology and inflammation. It functions as an integrin antagonist, specifically targeting α4β1 integrin, which plays a critical role in the adhesion and migration of immune cells. This mechanism makes it a promising candidate for treating inflammatory and autoimmune conditions, such as multiple sclerosis and inflammatory bowel disease. By inhibiting the interaction between immune cells and vascular endothelium, it may help reduce inflammation and prevent tissue damage in these disorders. Research is ongoing to evaluate its efficacy and safety in clinical settings.